RheumNow Podcast – Good Time Charlie…. (10.16.20)
Oct 15, 2020
Dr. Jack Cush sings the news and journal reports from the past week on RheumNow.com.
Read Article
1) If you are have diffuse scleroderma and have previously participated in a clinical trial, we need your help! You will be asked to watch video tutorial and answer a survey which will take you 20 minutes to complete. the study is supported by @WeAreSRUK @scleroderma @srfcure
Dr. Dinesh Khanna sclerodermaUM ( View Tweet)
Oct 06, 2020
Slow Lung Decline Typical in Systemic Sclerosis
Sep 30, 2020
The interstitial lung disease that develops in a subset of patients with systemic sclerosis tends to be heterogeneous, with the majority of patients experiencing a slow pattern of decline in lung function, analysis of outcomes in the European Scleroderma Trials and Research (EUSTAR) database
Read Article
Novel Biologic Promising in Mid-Stage Scleroderma Trial
Sep 29, 2020
The anti-interleukin agent romilkimab showed significant benefits on skin fibrosis among patients with systemic sclerosis in a phase II trial, researchers reported.
At week 24, the least squares mean change from baseline on the modified Rodnan skin score was -4.76 for patients
Read Article
RheumNow Podcast – Cardiovascular Risk in Psoriatic Disease (9.25.20)
Sep 24, 2020
Dr. Jack Cush reviews the news and Journal articles from the past week on RheumNow.com.
Read Article
Romilkimab Effective in Early Diffuse Systemic Sclerosis
Sep 24, 2020
A phase II study of patients with early diffuse systemic sclerosis (SSc) has demonstrated improvement in SSc skin outcomes by targeting T cells and fibrosis with the bispecific monoclonal antibody romilkimab (RMK).
Romilkimab is an engineered, humanised, bispecific immunoglobulin-G4
Read Article
Is Mortality Improving in Systemic Sclerosis?
Aug 16, 2020
Systemic sclerosis (SSc) is a progressive autoimmune disorder that causes premature death, usually from lung, GI, or renal disease. While treatment efforts have been frustrating advances in care may have altered the risk of death according to population data showing that while SSc mortality
Read Article
The RheumNow Podcast is up - Top 13 Rheumatology Centers in the US; anakinra & colchicine in COVID, unload the loading dose, CB2 in Scleroderma.
Dr. John Cush RheumNow ( View Tweet)
Aug 02, 2020
Spanish registry of 3679 SLE pts finds 13.6% had polyautoimmunity (SLE plus another autoimmune Dz), Dx as thyroiditis (8%), Sjogrens (14%) secondary APS (14%).
Links:
Dr. John Cush RheumNow ( View Tweet)
Jul 31, 2020
RheumNow Podcast - Top 13 Rheumatology Centers (7-31-20)
Jul 31, 2020
Dr. Jack Cush reviews the news and TOP 13 list of Best Rheumatology Hospitals.
Read Article
RheumNow Podcast is Up! Listen to Fauci! Watch it here>> https://t.co/dHq3fP85Ip or Listen to the Podcast>> https://t.co/LdHO7fKUCp
Dr. John Cush RheumNow ( View Tweet)
Jul 17, 2020
RheumNow Podcast – LTF – Listen to Fauci (7.17.20)
Jul 17, 2020
Dr. Jack Cush reviews the news, tweets and journal articles from the past week on RheumNow. Let's dig into this week's 14 highlights.
Ghent Univ experience and literature review shows that diffuse and localized scleroderma occurs in 2.4 to 7.4% often with Raynauds (6/8), scleroderma pattern on nailfold videocapillaroscopy and SSc-specific autoantibodies https://t.co/zDgXsuKD3p
Links:
Dr. John Cush RheumNow ( View Tweet)
Jul 16, 2020
Virtual EULAR 2020 Round Up
Jun 12, 2020
In this week's podcast, Drs. Artie Kavanaugh and Jack Cush present highlights from the virtual EULAR2020 meeting held June 3-6, 2020. Featured reports include the SELECT-CHOICE study, the EXCEED trial, Avacopan in AAV, BeST mortality outcomes, BLISS-LN study, biosimilars and tofa in systemic
Read Article
Day 3 - Top 5 from EULAR 2020
Jun 10, 2020
These were my top abstracts from Thursday, 4th of June at EULAR 2020:
Read Article
Day 2 – Top 5 from EULAR 2020
Jun 09, 2020
These were my top abstracts from Thursday, 4th of June at EULAR 2020.
Read Article
Yet another NEGATIVE Trial in Hand OA. Add Hand OA to the list that Includes Scleroderma, Sjogrens and CRPS as untreatable diseases with large unmet needs! https://t.co/cMMqmeo19N
Dr. John Cush RheumNow ( View Tweet)
Jun 05, 2020
First Look at COVID-19 Global Rheumatology Alliance Registry
Jun 01, 2020
Gianfresco et al have published the first peer-reviewed analysis of COVID-19 infected, rheumatic disease patients entered into the Rheumatology Global Alliance registry; showing that a) rheumatic disease patient can be infected with COVID-19, b) that DMARD and biologic use has no apparent effect
Read Article
Systemic Sclerosis Future Therapies and Outcome Measures
May 19, 2020
Nagaraja, Khanna and colleagues have published an overview of current and future therapies in patients with systemic sclerosis (SSc) and have reviewed the potential outcome measures for this difficult autoimmune disorder. Notably there have been several novel agents studied in recent years,
Read Article
RheumNow Podcast – The Beat Goes On (5.8.20)
May 07, 2020
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.
Lenabasum Encouraging in Systemic Sclerosis
Apr 30, 2020
The oral cannabinoid receptor type 2 (CB2) agonist lenabasum showed promising results for systemic sclerosis (SSc) in a phase II study.
At week 16, the American College of Rheumatology Combined Response Index in diffuse cutaneous Systemic Sclerosis (CRISS) increased to 0.33 among
Read Article
RheumNow Podcast – In Times of Trouble (4.24.20)
Apr 24, 2020
Dr Jack Cush reviews the news, journal reports, twitter feed and COVID developments from the past week on RheumNow.com
Read Article
Treatment of Statin-induced anti-HMGCR myopathy
Jan 10, 2020
Statin-induced myositis, often with anti-HMGCR autoantibodies can be difficult to manage, Arthritis Research & Therapy yhas published the experience of 55 patient with HMGCR myopathy, demonstrating that while steroid management may be reasonable in select patients, the use of
Read Article
CRP in SSc: Identifying a Severe Phenotype
Dec 12, 2019
Patients with systemic sclerosis (SSc) who have persistent inflammation -- characterized by consistently elevated levels of C-reactive protein (CRP) -- have more severe disease and worse outcomes, a retrospective study confirmed.
In a cohort of 131 patients, those with the inflammatory
Read Article
RheumNow Podcast – Believe in Vitamin D or Rituximab? (9.20.19)
Sep 20, 2019
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
Read ArticleRecent Blogs
Will the results of two recent large scleroderma lung studies finally inform us on how to manage interstitial lung disease in systemic sclerosis?
Read Post
